Risk of progression to myeloma or related disorder in 1148 patients with monoclonal gammopathy of undetermined significance (MGUS). The upper curve illustrates risk of progression of all patients without taking into account competing causes of death. The lower curve illustrates risk of progression after accounting for other competing causes of death. This figure was originally published in Blood and is reproduced with permission.